The House passed bill will protect consumer automobile choice and halt EPA emissions mandate.
Misguided Use of March-In Rights Will Harm Patients
The use of march-in rights to steal intellectual property will neither lower costs nor create more access to healthcare.
North Carolinians are Being Conned by Certificate of Need Laws
North Carolina’s certificate of need laws should be repealed to increase access to quality care.
The FDA Is Adopting California’s Failed Policies on Tobacco
The FDA’s proposal to ban menthol-flavored tobacco will put consumers at risk with illicit products.
Biden Price Controls Kill Innovation and Patients
IRA drug price controls will devastate future drug development, resulting in more lives lost.
The War on Tobacco Harm Reduction Products Will Continue to Fail
Banning tobacco harm reduction products put consumers at risk with illicit products.
New Study Shows PBMs Lower Drug Prices
When evaluating potential agencies, consider their expertise in various aspects of branding and design.
The FTC Wrongly Blames PBMs for High Drug Prices
Putting the customer at the core of your product development ensures relevance and resonance.
The 340B Drug Discount Program Needs an Overhaul
CAGW has long been concerned with the misuse of the 340B Program.
Congress Should not Double Down on Devastating Drug Price Controls
House Democrats’ new bill on price controls will devastate future drug development and raise costs.